Company Filing History:
25 out of 27 
10 out of 11 
1 out of 822 
Years Active: 2012-2022
Title: Oliver Hill: Innovator in Biotechnology and Cytokine Research
Introduction
Oliver Hill, an accomplished inventor located in Neckarsteinach, Germany, holds a remarkable portfolio of 35 patents. His work primarily focuses on the development of innovative single-chain fusion proteins, which have significant implications for therapeutic and diagnostic applications.
Latest Patents
Among his latest contributions are several groundbreaking patents. One includes "Light single-chain fusion polypeptides, encoding nucleic acid molecules and host cells," which encompasses single-chain fusion proteins composed of three soluble TNF superfamily cytokine domains. The invention is designed to produce fusion proteins that are substantially non-aggregating, making them ideal for therapeutic, diagnostic, and research applications.
Another notable patent is for "Single-chain glucocorticoid-induced tumor necrosis factor receptor (GITR) receptor agonist proteins." This invention includes specific GITR receptor agonist proteins and nucleic acids that encode them, as well as methodologies for treating diseases associated with GITRL. These proteins are also designed to be substantially non-aggregating, further enhancing their suitability for various applications.
Career Highlights
Oliver Hill has made substantial contributions to the field while working with several prominent companies, including Apogenix AG and Apogenix GmbH. His dedication to innovation has led to meaningful advancements in biotechnology, particularly in the realm of cytokine research.
Collaborations
Throughout his career, Hill has collaborated with esteemed colleagues, including Christian Gieffers and Meinolf Thiemann. These partnerships have fostered a collaborative environment that promotes innovation and discovery in biotechnology.
Conclusion
With a solid number of patents and a strong collaborative network, Oliver Hill stands out as a significant figure in the field of biotechnology. His innovative approaches to protein design and therapeutic development are paving the way for advancements in treatment options for various diseases.